News and Accolades

Under the leadership of Dr. Quyen Nguyen, pulmonary specialists anchor a multidisciplinary approach to diagnosing and managing this complex vascular disease.

Recent studies from Drs. Benam, Chandra, Strollo, and Rivera-Lebron examine disease mechanisms, risk stratification, and long-term outcomes across pulmonary conditions.

Dr. Ian Barbash reflects on the care he received during a recent ICU stay and the lasting impact it’s had on his approach to patients and colleagues in a recent UPMC First Friday feature.

As spring allergies surge in Western Pennsylvania, DOM physicians are helping patients manage symptoms while advancing research in severe, treatment-resistant asthma with more personalized and effective therapies.

Led by Jesus Tejero, PhD, at Pitt’s Vascular Medicine Institute, researchers have developed a fast, portable therapy that could change how carbon monoxide poisoning is treated in emergencies.

In the Nature Communications study led by Melanie Königshoff, MD, PhD, lysyl oxidase was shown to fuel scarring with an existing drug serving as a new potential treatment.

Research led by Jesus Tejero, PhD, has found that a novel protein therapy, RcoM-HBD-CCC, clears CO from the bloodstream faster than current treatments, with potential for use by first responders in the field.

A new study led by Dr. Frank Sciurba, published in The New England Journal of Medicine, reveals that mepolizumab can significantly reduce exacerbations in COPD patients with eosinophilic inflammation—affecting up to 40% of those with the disease.